ArticleImmuno-oncology technology2026

Safety and feasibility of blood-derived multiple antigen-specific endogenously derived T cells (MASE-T) for metastatic melanoma.

T J Monberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.